Weina Ke

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs)”.

Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs)

Advanced Drug Delivery Reviews(2021)10.1016/j.addr.2021.113835

N/A

0DataRank · unranked

93 citations

Kirill A. Afonin, Weina Ke

Critical review of nucleic acid nanotechnology to identify gaps and inform a strategy for accelerated clinical translation

Advanced Drug Delivery Reviews(2021)10.1016/j.addr.2021.114081

N/A

0DataRank · unranked

68 citations

Marina A. Dobrovolskaia, Weina Ke, Piotr Grodzinski, Mark Bathe, Kirill A. Afonin

Aptamer Conjugated RNA/DNA Hybrid Nanostructures Designed for Efficient Regulation of Blood Coagulation

Methods in molecular biology(2023)10.1007/978-1-0716-3417-2_19

N/A

0DataRank · unranked

1 citations

Weina Ke, Kirill A. Afonin, Lewis A. Rolband

Transforming Cancer Nanotechnology Data Analysis and User Experience. Part I: Current Challenges and Solutions Provided by caNanoLab

Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology(2025)10.1002/wnan.70030

N/A

0DataRank · unranked

1 citations

Rui He, Mark A. Jensen, Marina A. Dobrovolskaia, Weina Ke

Transforming Cancer Nanotechnology Data Analysis and User Experience. Part II: Providing Future Solutions Using Large Language Models

Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology(2025)10.1002/wnan.70029

N/A

0DataRank · unranked

0 citations

Rui He, Mark A. Jensen, Marina A. Dobrovolskaia, Weina Ke